From Our Readers

From Our Readers

Don’t Fear the Filter

To the Editor: As an interventional radiologist who specializes in acute and chronic deep-vein thrombosis (DVT), superficial venous disease, and complex filter removal, I applaud...

Crippling Clinical Research?

I commend Dr. Sekeres for his excellent editorial (Take My Leftover Tissue, Please!), which appeared in the December 2015 issue of ASH Clinical News....

U.S. Medicine Prices: Watching from Europe with Trembling Knees

Working at the Dana-Farber Cancer Institute (then the Sidney Farber) in the Division of Tumor Immunology led by Stuart Schlossman, MD, in the early...

The Roadmap Forward in Follicular Lymphoma: Time for a Precision Approach

Over the past two decades, improved diagnostic accuracy and novel therapeutic approaches have resulted in profound improvements in overall survival in patients with follicular...

The Present and Future Multiple Myeloma Landscape

The rapid pace of drug approvals in multiple myeloma (MM) shows no sign of abating. In the past two years, the U.S. Food and...

The Cost of Treating Thrombosis

In their interesting debate (“Drawing First Blood: For Anticoagulation in Cancer-Associated Thrombosis, Is Less More?”) in the August issue of ASH Clinical News, David Garcia, MD, and...

The Debate on IVC Filters

To The Editor: I offer my views in response to the debate on IVC filters. Numerous papers have been published with varying degrees of scientific...
Advertisement

Current Issue

February 2019, Volume 5, Issue 3

This issue features a look at the unique challenges of developing treatments for orphan diseases, more coverage of the 2018 ASH annual meeting, and more.